Ketone Ester and Acute Salt (KEAS) in Young Adults

NARecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

March 24, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2026

Conditions
Salt; ExcessHypertension
Interventions
DIETARY_SUPPLEMENT

No Salt, No β-OHB

Participants will consume the following for ten days. Enteric capsules will be filled with a dextrose placebo. The placebo supplement will be a β-OHB-free, taste and viscosity-matched, beverage produced by KetoneAid.

DIETARY_SUPPLEMENT

High Salt, No β-OHB

Participants will consume the following for ten days. Enteric capsules will be filled with Morton's table salt. Sodium consumption will be normalized to caloric intake (2 mg Sodium/Calorie). The placebo supplement will be a β-OHB-free, taste and viscosity-matched, beverage produced by KetoneAid.

DIETARY_SUPPLEMENT

High Salt, High β-OHB

Participants will consume the following for ten days. Enteric capsules will be filled with Morton's table salt. Sodium consumption will be normalized to caloric intake (2 mg Sodium/Calorie). Ketone beverage will be the β-OHB supplement produced by KetoneAid. Participants will consume 24 mL (12 grams β-OHB) of the ketone beverage three times a day (total 36 grams β-OHB).

Trial Locations (1)

36849

RECRUITING

Auburn University, Auburn

All Listed Sponsors
collaborator

University of Utah

OTHER

collaborator

University of Missouri-Columbia

OTHER

collaborator

Indiana University

OTHER

lead

Auburn University

OTHER